Loading...

Clinical use of ruxolitinib in an academic medical center in unselected patients with myeloproliferative neoplasms not on clinical study

Ruxolitinib is the only approved therapy for myelofibrosis (MF). However, its use in patients with myeloproliferative neoplasms (MPN) not participating in clinical studies has been poorly described. We reviewed the medical records of 45 patients (35 MF, 10 others) treated with ruxolitinib at our cen...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Leuk Lymphoma
Main Authors: Naqvi, Kiran, Daver, Naval, Pemmaraju, Naveen, Bose, Prithviraj, Cortes, Jorge, Kantarjian, Hagop, Verstovsek, Srdan
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5521009/
https://ncbi.nlm.nih.gov/pubmed/27494751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2016.1217528
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!